Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Haritaki and Reduced Standard Care Medication Need

Doses used in studies

mg/day: 1,000 (median 1,000, IQR 1,000–1,000) — 1 study

Time to effect

Median: 6 months · IQR 6 months–6 months · Range 6 months–6 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
Safety will be evaluated by recording the incidence of adverse events and changes in laboratory safety parameters (CBC, LFT, KFT) from baseline.
from: Efficacy of Ayurveda interventions (Pushkar Guggulu and Haritaki) as an adjunct to standar

1 of 1 paper

Efficacy of Ayurveda interventions (Pushkar Guggulu and Haritaki) as an adjunct to standard care in stable coronary artery disease: study protocol for a double-blind, randomized controlled study.
- 2026-01-24
- RCT · n = 100
- BMC complementary medicine and therapies 26(1)
- - Sakshi Sharma
  - Anunay Gupta
  - Amit K Rai
  - Puneet Gupta
  - Bharti Gupta
  - Bhagwan S Sharma
  - Rakesh K Rana
  - Bhogavalli Chandrasekhararao
  - Narayanam Srikanth
  - Rabinarayan Acharya
- PubMed: 41580651
- DOI: 10.1186/s12906-025-05204-2
8 Insights on
- Reduced Standard Care Medication Need
- High evidence
- Large Human Trial
the change in the need for standard care medications for CAD from baseline
Effect
Neutral
Effect size
Small
Significant
No
Dose
500 mg twice daily after meals